PeptideDB

J30-8 2366255-71-0

J30-8 2366255-71-0

CAS No.: 2366255-71-0

J30-8 is a highly efficient, isoform-selective JNK3 conjugate with IC50 of 40 nM and 2500-fold selectivity over JNK1α1
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

J30-8 is a highly efficient, isoform-selective JNK3 conjugate with IC50 of 40 nM and 2500-fold selectivity over JNK1α1 and JNK2α2 isoforms. J30-8 has neuro-protection activity in vitro and has current potential for studying neurodegeneration.

Physicochemical Properties


Molecular Formula C17H9CLFN3O2S
Molecular Weight 373.788664579391
Exact Mass 373.008
CAS # 2366255-71-0
PubChem CID 4078145
Appearance Brown to red solid powder
LogP 3.9
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 3
Heavy Atom Count 25
Complexity 721
Defined Atom Stereocenter Count 0
SMILES

ClC1C=CC=CC=1NC1=NC(=C(C2C(N=C3C=CC(=CC=23)F)=O)S1)O

InChi Key BDCJVPSBCYWSSS-UHFFFAOYSA-N
InChi Code

InChI=1S/C17H9ClFN3O2S/c18-10-3-1-2-4-12(10)21-17-22-16(24)14(25-17)13-9-7-8(19)5-6-11(9)20-15(13)23/h1-7,24H,(H,21,22)
Chemical Name

3-[2-(2-chloroanilino)-4-hydroxy-1,3-thiazol-5-yl]-5-fluoroindol-2-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases. J Med Chem. 2019 Jul 25;62(14):6645-6664.


Solubility Data


Solubility (In Vitro) DMSO : ~6.67 mg/mL (~17.84 mM)
Solubility (In Vivo) Solubility in Formulation 1: 0.67 mg/mL (1.79 mM) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 6.7 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6753 mL 13.3765 mL 26.7530 mL
5 mM 0.5351 mL 2.6753 mL 5.3506 mL
10 mM 0.2675 mL 1.3376 mL 2.6753 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.